Novartis Files Third Patent Suit Over Generic Lotrel
Novartis Corp. has stuck Par Pharmaceuticals with a patent infringement lawsuit over the hypertension drug Lotrel, marking the third suit Novartis has brought against a generic pharmaceutical company that has asserted...To view the full article, register now.
Already a subscriber? Click here to view full article